I-Mab, a clinical-stage biopharmaceutical company, will establish a new site focusing on Translational Medicine and Formulation Research in San Diego. The state-of-the-art, integrated laboratory and office space will bolster worldwide development capabilities to conduct global clinical studies across China and the U.S.   “Our vision for our new San Diego location is to establish a world-class research and operational site as part of I-Mab US R&D Center that will support our mission t...